COPD does not directly grow lung nodules the way a tumor does, but it creates conditions that make nodules far more likely to appear on a CT scan. Chronic inflammation, repeated infections, and the structural damage that define COPD all contribute to nodule formation, and the overlap between the two conditions is common enough that clinicians expect to find nodules when imaging COPD patients. The relationship goes deeper than coincidence, though, because the same nodules that look harmless can sometimes signal early-stage lung cancer, and COPD independently raises that risk.
Why Nodules Show Up in COPD Lungs
The lungs of someone with COPD are in a state of ongoing low-grade inflammation. Airways are chronically irritated, immune cells are persistently active, and the lung tissue itself undergoes repeated cycles of damage and attempted repair. Each of those cycles can leave behind small scars or clumps of inflammatory tissue that show up as nodules on imaging. These are sometimes called inflammatory nodules, and they are among the most common incidental findings when COPD patients get a chest CT for any reason.
Infections play a role too. People with COPD are more susceptible to lung infections, and certain organisms leave distinctive nodular traces. A study of semi-invasive pulmonary aspergillosis in COPD patients found that the fungal infection produced nodules larger than one centimeter in diameter, sometimes with central cavitation and surrounding hemorrhage, alongside aspergillus colonies embedded in the lung tissue itself.1PubMed. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients Bacterial infections, mycobacterial disease, and even old, healed infections can all produce similar-looking spots on a scan. When your immune system walls off an infection site, the resulting granuloma is, structurally, a nodule.
Beyond infection and inflammation, the physical remodeling of COPD lungs contributes. Fibrosis, the thickening and scarring of tissue around damaged airways, can create focal areas dense enough to register as nodules. In other words, the same destructive processes that cause breathlessness and airflow limitation are also the processes that generate small spots visible on CT.
How Common Are Nodules in People With COPD
Nodules in COPD patients are not rare findings. A multicenter trial comparing low-dose CT to MRI for detecting lung nodules enrolled 567 participants with COPD and found a total of 525 nodules larger than 3 mm across 178 of those participants. That means roughly a third of the COPD patients scanned had at least one nodule.2PubMed Central. MRI Compared with Low-Dose CT for Incidental Lung Nodule Detection in COPD: A Multicenter Trial The average nodule size was about 7 mm, and they ranged from just over 3 mm up to more than 6 cm.
Data from the COPDGene cohort, a large observational study of people with COPD, adds more texture. Participants who had nodules 6 mm or larger tended to be older, had smoked more, and had more emphysema on their scans than participants without nodules.3American Journal of Respiratory and Critical Care Medicine. B44-24 Clinical Characteristics of Participants With Pulmonary Nodules in COPDgene Cohort Emphysema and gas trapping were measurably worse in the group with nodules. This does not mean every COPD patient will have nodules, but it does mean that the worse your airflow limitation and lung destruction, the more likely you are to have them.
The Lung Cancer Question
This is the part that understandably worries people most. Finding a lung nodule does not mean you have cancer, and in fact the majority of nodules in COPD patients are benign. But COPD is an independent risk factor for lung cancer, even after you account for smoking history. The chronic pro-inflammatory environment that COPD creates appears to facilitate the kind of cellular changes that can eventually become malignant.3American Journal of Respiratory and Critical Care Medicine. B44-24 Clinical Characteristics of Participants With Pulmonary Nodules in COPDgene Cohort
A study using data from a large U.S. lung cancer screening trial found that either emphysema alone or lung nodules alone raised lung cancer risk, but the combination of both pushed the risk even higher and was also associated with greater all-cause mortality.4PubMed Central. Association of Lung Cancer Risk With the Presence of Both Lung Nodules and Emphysema in a Lung Cancer Screening Trial A separate analysis focused on emphysema confirmed that visible emphysema on CT is an independent risk factor for lung cancer, regardless of how much someone smoked.5PubMed Central. Emphysema and lung cancer risk The practical consequence is that a nodule found in someone with COPD and emphysema warrants closer attention than the same nodule in someone with healthy lungs.
An analysis using quantitative CT scoring found that lung cancer was more likely to develop in the upper lobes and in lobes with the most emphysema. Lobes ranked highest for emphysema had roughly two and a half times the odds of harboring a cancer compared to less-affected lobes.6PubMed Central. Severity of pulmonary emphysema and lung cancer: analysis using quantitative lobar emphysema scoring This spatial correlation, cancers clustering where emphysema is worst, reinforces the idea that tissue destruction and chronic inflammation create a local environment where malignancy can take hold.
When Nodules Are Not Cancer and Not Inflammation
Not every nodule in a COPD lung fits neatly into the “inflammation versus cancer” framing. Some have entirely different causes. Granulomas from past fungal infections like histoplasmosis are common in certain geographic regions and are completely benign. Hamartomas, small clusters of normal tissue growing in an abnormal location, account for another slice of benign nodules. One surgical series of COPD patients who had nodules removed during lung volume reduction surgery found six granulomas, two hamartomas, and three cancers among the resected specimens.4PubMed Central. Association of Lung Cancer Risk With the Presence of Both Lung Nodules and Emphysema in a Lung Cancer Screening Trial
Environmental exposures beyond cigarette smoke can also produce nodules. A case report described a man who had worked at a charcoal plant in Mexico, burning wood and inhaling massive amounts of smoke for years. His CT showed thickened airways with nodules, and biopsy revealed carbon-laden immune cells and fibrotic scars rather than cancer. He was diagnosed with “hut lung,” a condition caused by chronic high-level exposure to biomass smoke.7PubMed Central. Case report: a case of wood-smoke-related pulmonary disease Biomass smoke is a recognized cause of COPD globally, and the nodules it produces can look alarming on imaging despite being nonmalignant.
Why Diagnosing Nodules Is Harder in COPD
The structural chaos of COPD lungs makes it harder for both humans and computers to evaluate nodules accurately. Emphysema creates holes, bullae, and irregular tissue density throughout the lung. A nodule sitting in a field of destroyed tissue looks different from one surrounded by normal lung, and those differences complicate the tools doctors use to assess risk.
PET scans, which detect metabolic activity to distinguish active tumors from inactive tissue, can produce misleading results in COPD patients. Infections, active granulomatous disease, and even general inflammation can all light up on a PET scan, mimicking the metabolic signature of cancer. This means a “positive” PET result in someone with COPD does not automatically indicate malignancy. It might reflect an active infection, an inflammatory flare, or some other non-cancerous process.
Artificial intelligence tools designed to automatically detect nodules on CT also struggle with emphysema. A study testing AI software against human radiologists found that the AI flagged significantly more false positives per scan in patients with emphysema compared to those without it. Human readers did not show the same disparity.8PubMed Central. Effect of emphysema on AI software and human reader performance in lung nodule detection from low-dose chest CT As automated detection becomes more common in screening programs, this emphysema-related false-positive problem could lead to unnecessary follow-up scans and biopsies for COPD patients unless the algorithms are specifically recalibrated.
Researchers have been exploring whether quantitative measurements of the lung tissue surrounding a nodule can help sort benign from malignant findings. One study found measurable differences in lung density parameters between patients with benign nodules and those with malignant ones. Interestingly, in both groups, the lobe containing the nodule had less emphysema than the rest of the lung, but overall, patients with malignant nodules had more widespread emphysema.9PubMed Central. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules These kinds of measurements are still mostly a research tool, but they point toward a future where the surrounding lung tissue helps inform the decision about what to do with a nodule.
Ground-Glass Nodules and Emphysema
Not all lung nodules are solid. Some appear as hazy, partly transparent spots on CT, called ground-glass nodules or subsolid nodules. These are of particular interest in COPD patients because they are sometimes early signs of adenocarcinoma, a type of lung cancer that has been increasing in frequency.
Evaluating ground-glass nodules in emphysematous lungs presents a specific technical challenge. Emphysema reduces the overall density of lung tissue, which means the contrast between a faint ground-glass nodule and the surrounding lung is diminished. A study that examined subsolid nodules in patients with emphysema used relative CT values rather than absolute ones, comparing each nodule’s density to the density of the surrounding emphysematous tissue. The researchers found that this approach could help differentiate pre-invasive lesions from invasive adenocarcinoma, with specific cutoff values achieving sensitivities and specificities in the range of 58 to 90 percent depending on the metric used.10PubMed Central. Use of relative CT values to evaluate the invasiveness of pulmonary subsolid nodules in patients with emphysema The takeaway for patients is that a ground-glass nodule in an emphysematous lung may need to be assessed with different reference points than the same nodule in a healthy lung.
Biopsy Risks Are Higher in COPD
When a nodule looks suspicious enough to biopsy, COPD adds a layer of complication. CT-guided needle biopsy of a lung nodule carries a well-known risk of pneumothorax, where air leaks out of the lung into the chest cavity. In people with COPD, that risk is substantially higher. A study comparing biopsy outcomes found that the pneumothorax rate was about 31 percent in COPD patients versus about 17 percent in non-COPD patients, and COPD was the only independent risk factor for this complication in the analysis.11PubMed. Incidence, severity and tolerability of pneumothorax following low-dose CT-guided lung biopsy in different severities of COPD
The reassuring nuance is that the severity of COPD did not make much difference once you already had it. The pneumothorax rate was similar across mild, moderate, and severe COPD, and even when a pneumothorax did occur, it was generally well tolerated and did not significantly add to the medical burden. Still, the elevated baseline risk means clinicians have to weigh the benefit of a definitive tissue diagnosis against a roughly one-in-three chance of a complication. For some nodules, especially small ones with low-risk features, watchful waiting with repeat imaging may be a better initial approach than an immediate biopsy.
How Systemic Inflammation Fits In
COPD is not just a lung disease. It produces chronic systemic inflammation, with elevated levels of inflammatory markers measurable in the blood. This systemic inflammatory state may itself contribute to nodule development. A large study in a Chinese population found that people with higher levels of common blood-based inflammation markers had an increased risk of having pulmonary nodules detected on screening. Those with the highest levels had roughly 10 to 20 percent greater odds of having a nodule compared to those with the lowest levels.12PubMed Central. Associations of systemic inflammation markers with identification of pulmonary nodule and incident lung cancer in Chinese population The same markers also showed associations with lung cancer risk, suggesting that systemic inflammation may be part of the pathway linking COPD, nodules, and eventual malignancy.
This does not mean a blood test can tell you whether your nodule is dangerous. But it does support the broader picture that the inflammatory burden COPD places on the body is not confined to airway symptoms. It creates a measurably higher-risk biological state that extends to how and why new growths form in the lungs.
Following Up on Nodules if You Have COPD
If you have COPD and a nodule has been found on your CT, you are actually more likely to receive guideline-appropriate follow-up care than someone without COPD. A study examining adherence to nodule management guidelines found that having a COPD diagnosis was associated with roughly 75 percent higher odds of guideline-concordant care, and being seen by a pulmonologist nearly doubled those odds.13PubMed Central. Patient characteristics associated with adherence to pulmonary nodule guidelines This likely reflects the fact that COPD patients are already plugged into a respiratory care system with regular imaging and specialist visits, making it harder for a nodule to slip through the cracks.
The follow-up itself typically involves repeat imaging at intervals determined by the nodule’s size, appearance, and the patient’s overall risk profile. Smaller, solid nodules in lower-risk individuals might warrant a follow-up CT in six to twelve months. Larger nodules, nodules with irregular edges, or those in patients with high emphysema burden and heavy smoking histories may need faster workup, including PET scans or biopsy. The presence of COPD shifts the risk calculus because, as the evidence reviewed above shows, the combination of emphysema and a nodule carries more cancer risk than either alone.
The Psychological Weight of Nodule Surveillance
Something that gets less attention in clinical conversations is how being told you have a lung nodule affects your mental state, especially when you already live with the chronic burden of COPD. A Swedish population-based study found that people undergoing nodule surveillance had nearly four times the odds of experiencing anxiety about lung cancer compared to those without nodules. They also reported more feelings of dejection and increased thoughts about existential concerns.14BMJ Open. Surveillance of indeterminate pulmonary nodules detected with CT in a Swedish population-based study (SCAPIS): psychosocial consequences and impact on health-related quality of life
For someone already managing the daily challenges of COPD, including breathlessness, activity limitations, and frequent medical appointments, the added uncertainty of a “watch and wait” nodule can be a significant psychological burden. Knowing that most nodules are benign helps intellectually, but the months between surveillance scans can still be stressful. If you find yourself in this situation, it is reasonable to ask your care team exactly what features of your nodule they are monitoring, what changes would trigger further action, and what the realistic probability of malignancy is given your specific characteristics. Having concrete information tends to be more calming than vague reassurance.
Surgical Considerations for COPD Patients With Suspicious Nodules
When a nodule does turn out to be cancerous or highly suspicious, the question of surgery becomes more fraught in someone with COPD. Poor lung function is one of the main reasons patients are deemed inoperable for early-stage lung cancer, and severe COPD can push lung function measurements to levels traditionally considered too low for safe surgical resection.
An interesting workaround has been demonstrated in patients with severe emphysema who were candidates for lung volume reduction surgery, a procedure that removes the most destroyed portions of the lung to allow the remaining tissue to function better. Surgeons have combined this procedure with nodule removal in the same operation. In one series, patients had average lung function measurements around 26 percent of predicted, well below what would normally be considered operable, yet simultaneous resection of nodules was feasible and led to improved lung function and reduced breathlessness afterward. The nodules removed in that series included both benign lesions and cancers, and the complication rates were manageable. This approach obviously applies only to a narrow subset of patients, those with severe emphysema concentrated in areas that overlap with suspicious nodules, but it shows that even advanced COPD does not always make treatment impossible.